Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population -: Results from the 14-year follow-up of a large cohort from southern Germany

被引:240
作者
Koenig, W
Khuseyinova, N
Löwel, H
Trischler, G
Meisinger, C
机构
[1] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89081 Ulm, Germany
[2] GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol, Inst Epidemiol, Neuherberg, Germany
[3] Augsburg Cent Hosp, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany
关键词
inflammation; risk factors; coronary disease; epidemiology; prognosis;
D O I
10.1161/01.CIR.0000143377.53389.C8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Chronic inflammation represents an essential feature of the atherosclerotic process. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)), an enzyme mainly produced by monocytes/macrophages, generates potent proinflammatory products. Methods and Results - Plasma concentrations of Lp-PLA(2) were determined by ELISA in 934 apparently healthy men aged 45 to 64 years sampled from the general population in 1984 and followed up until 1998. During this period, 97 men experienced a coronary event diagnosed according to the MONICA (MONItoring of trends and determinants in CArdiovascular disease) protocol. Baseline levels of Lp-PLA(2) were higher in subjects who experienced an event than in event-free subjects (295 +/- 113 versus 263 +/- 79 ng/mL, P < 0.01). Lp-PLA(2) was positively correlated with total cholesterol ( R = 0.30, P < 0.0001) and age ( R = 0.12, P = 0.001), was only slightly correlated with HDL cholesterol (R = 0.09, P = 0.005) and C-reactive protein R = 0.06, P = 0.06), but was not correlated with body mass index or blood pressure. In a Cox model, a 1-SD increase in Lp-PLA(2) was associated with risk of future coronary events ( hazard ratio [HR] 1.37, 95% CI 1.16 to 1.62). After controlling for potential confounders, the HR was attenuated but remained statistically significant ( HR 1.23, 95% CI 1.02 to 1.47). Further inclusion of C-reactive protein in the model did not appreciably affect its predictive ability ( HR 1.21, 95% CI 1.01 to 1.45). Conclusions - Elevated levels of Lp-PLA(2) appeared to be predictive of future coronary events in apparently healthy middle-aged men with moderately elevated total cholesterol, independent of CRP. This suggests that Lp-PLA(2) and CRP may be additive in their ability to predict risk of coronary heart disease.
引用
收藏
页码:1903 / 1908
页数:6
相关论文
共 30 条
  • [1] [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI DOI 10.1016/0895-4356(88)90084-4
  • [2] [Anonymous], 1998, CVD Prevention
  • [3] Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma
    Asano, K
    Okamoto, S
    Fukunaga, K
    Shiomi, T
    Mori, T
    Iwata, M
    Ikeda, Y
    Yamaguchi, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 261 (02) : 511 - 514
  • [4] Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study
    Ballantyne, CM
    Hoogeveen, RC
    Bang, H
    Coresh, J
    Folsom, AR
    Heiss, G
    Sharrett, AR
    [J]. CIRCULATION, 2004, 109 (07) : 837 - 842
  • [5] A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events in women
    Blake, GJ
    Dada, N
    Fox, JC
    Manson, JE
    Ridker, PM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (05) : 1302 - 1306
  • [6] Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase:: a potential new risk factor for coronary artery disease
    Caslake, MJ
    Packard, CJ
    Suckling, KE
    Holmes, SD
    Chamberlain, P
    Macphee, CH
    [J]. ATHEROSCLEROSIS, 2000, 150 (02) : 413 - 419
  • [7] Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease
    Caslake, MJ
    Packard, CJ
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2003, 14 (04) : 347 - 352
  • [8] Dada Nisha, 2002, Expert Rev Mol Diagn, V2, P17
  • [9] Major risk factors as antecedents of fatal and nonfatal coronary heart disease events
    Greenland, P
    Knoll, MD
    Stamler, J
    Neaton, JD
    Dyer, AR
    Garside, DB
    Wilson, PW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07): : 891 - 897
  • [10] Improving coronary heart disease risk assessment in asymptomatic people - Role of traditional risk factors and noninvasive cardiovascular tests
    Greenland, P
    Smith, SC
    Grundy, SM
    [J]. CIRCULATION, 2001, 104 (15) : 1863 - 1867